Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 15, Issue 6, 2008, Pages 709-718

  Napoli, Claudio ^a,d,e   Farzati, Bartolomeo ^a   Sica, Vincenzo ^a   Iannuzzi, Emanuele ^b   Coppola, Giuseppe ^f   Silvestroni, Andrea ^f   Balestrieri, Maria Luisa ^d   Florio, Anna ^c   Matarazzo, Angelo ^c  

^a Division of Clinical Pathology   (Italy)

^b Division Anesthesiology   (Italy)

^c Vascular Access Surgery Villa dei Fiori   (Italy)

^d 1st School of Medicine   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Intervention Vascular Unit and Laser Doppler Measurements   (Italy)

Author keywords

Antioxidants; Bone marrow cells; L arginine; Peripheral arterial disease

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMLODIPINE; ANTICOAGULANT AGENT; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CANRENOATE POTASSIUM; CARVEDILOL; CLOPIDOGREL; DIGOXIN; DILTIAZEM; ENALAPRIL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; ILOPROST; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; LISINOPRIL; LOSARTAN; LOW MOLECULAR WEIGHT HEPARIN; PENTOXIFYLLINE; PERINDOPRIL; PROSTANOID; PROSTAVASIN; RAMIPRIL; TICLOPIDINE; VALSARTAN; WARFARIN;

ADULT; AGED; ANGIOGENESIS; ANKLE BRACHIAL INDEX; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BELOW KNEE AMPUTATION; CAPILLAROSCOPY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMORAL ANGIOGRAPHY; HUMAN; LASER DOPPLER FLOWMETRY; LEG ARTERY; LIMB ISCHEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WALKING; AMPUTATION; ANGIOSCOPY; ANKLE; ATHEROSCLEROSIS; AUTOTRANSPLANTATION; BLOOD PRESSURE; BONE MARROW TRANSPLANTATION; BRACHIAL ARTERY; CHRONIC DISEASE; CONVALESCENCE; CRITICAL ILLNESS; DRUG EFFECT; FEASIBILITY STUDY; ISCHEMIA; LEG; LEG ULCER; MICROCIRCULATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; TIME; VASCULARIZATION;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANKLE; ANTIOXIDANTS; ARGININE; ATHEROSCLEROSIS; BLOOD PRESSURE; BONE MARROW TRANSPLANTATION; BRACHIAL ARTERY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; FEASIBILITY STUDIES; FEMALE; HUMANS; ISCHEMIA; LASER-DOPPLER FLOWMETRY; LEG ULCER; LOWER EXTREMITY; MALE; MICROCIRCULATION; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; RECOVERY OF FUNCTION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WALKING;

EID: 64749115434     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e3283193a0f     Document Type: Article

References (35)

1. Aronow WS. Management of peripheral arterial disease. Cardiol Rev 2005; 13:61-68.
2. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006; 10:45-55.
3. Hamano K, Li TS, Kobayashi T, Tanaka N, Kobayashi S, Matsuzaki M, et al. The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method. Surgery 2001; 130:44-54.
4. Muhs BE, Gagne P, Sheehan P. Peripheral arterial disease: clinical assessment and indications for revascularization in the patient with diabetes. Curr Diab Rep 2005; 5:24-29.
5. Napoli C, Maione C, Schiano C, Fiorito C, Ignarro LJ. Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. Trends Mol Med 2007; 13:278-286.
6. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-674.
7. de Nigris F, Lerman A, Ignarro LJ, Williams-Ignarro S, Sica V, Baker AH, et al. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med 2003; 9:351-359.
8. Boak L, Chin-Dusting JP. Hypercholesterolemia and endothelium dysfunction: role of dietary supplementation as vascular protective agents. Curr Vasc Pharmacol 2004; 2:45-52.
9. Napoli C, Sica V, Pignalosa O, de Nigris F. New trends in anti-atherosclerotic agents. Curr Med Chem 2005; 12:1755-1772.
10. Cooke JP, Oka RK. Atherogenesis and the arginine hypothesis. Curr Atheroscler Rep 2001; 3:252-259.
11. Napoli C, Williams-Ignarro S, de Nigris F, de Rosa G, Lerman LO, Farzati B, et al. Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. Proc Natl Acad Sci U S A 2005; 102:17202-17206.
12. de Nigris F, Williams-Ignarro S, Sica V, D'Armiento FP, Lerman LO, Byrns RE, et al. Therapeutic effects of concurrent autologous bone marrow cell infusion and metabolic intervention in ischemia-induced angiogenesis in the hypercholesterolemic mouse hindlimb. Int J Cardiol 2007; 117:238-243. (Pubitemid 46463981)
13. Sica V, Williams-Ignarro S, de Nigris F, D'Armiento FP, Lerman LO, Balestrieri ML, et al. Autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the diabetic mouse hindlimb. Cell Cycle 2006; 5:2903-2908.
14. de Nigris F, Balestrieri ML, Williams-Ignarro S, D'Armiento FP, Lerman LO, Balestrieri ML, et al. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J Cardiovasc Pharmacol 2007; 50:424-433.
15. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360:427-435.
16. Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, et al. Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 2004; 109:1215-1218.
17. Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol 2005; 63:351-360.
18. Hernández P, Cortina L, Artaza H, Pol N, Lam RM, Dorticós E, et al. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis 2006; 194:e52-e56.
19. Bartsch T, Brehem M, Zeus T, Strauer BE. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs 2006; 21:430-432.
20. Bartsch T, Brehm M, Zeus T, Kögler G, Wernet P, Strauer BE. Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (The TAM-PAD study). Clin Res Cardiol 2007; 96:891-1889
21. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW, Karmody A, Whittemore AD, et al. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986; 4:80-94.
22. Yvonne-Tee GB, Rasool AH, Halim AS, Rahman AR. Noninvasive assessment of cutaneous vascular function in vivo using capillaroscopy, plethysmography and laser-Doppler instruments: its strengths and weaknesses. Clin Hemorheol Microcirc 2006; 34:457-473.
23. Napoli C, Sica V, de Nigris F, Pignalosa O, Condorelli M, Ignarro LJ, et al. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 2004; 148:e5-e12.
24. Crimi E, Liguori A, Condorelli M, Cioffi M, Astuto M, Bontempo P, et al. The beneficial effects of antioxidant supplementation in enteral feeding in critically ill patients: a prospective, randomized, double-blind, placebo-controlled trial. Anesth Analg 2004; 99:857-863.
25. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 2000; 102:E73-E86.
26. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, et al. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006; 116:652-662.
27. Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, et al. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol 2008; 80: 258-264.
28. Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, et al. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000; 101:2160-2164.
29. Violi F, Loffredo L, Mancini A, Marcoccia A. Antioxidants in peripheral arterial disease. Curr Drug Targets 2003; 4:651-655.
30. Napoli C, Ignarro LJ. Nitric oxide-releasing drugs. Annu Rev Pharmacol Toxicol 2003; 43:97-123.
31. Wilson AM, Harada R, Nair N, Balsubramanian N, Cooke JP. L-Arginine Supplementation in peripheral arterial disease. No benefit and possible harm. Circulation 2007; 116:188-195.
32. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104:1046-1052.
33. Burt RK, Loh Y, Pearce W, Beohar N, Barr WG, Craig R, et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. J Am Med Assoc 2008; 299:925-936.
34. Alexopoulos N, Vlachopoulos C, Aznaouridis K, Baou K, Vasiliadou C, Pietri P, et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 2008; 15:300-305.
35. Laufs U, Urhausen A, Werner N, Scharhag J, Heitz A, Kissner G, et al. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur J Cardiovasc Prev Rehabil 2005; 12:407-414.